AMD: Brolucizumab Noninferior to Aflibercept in Early Study AMD: Brolucizumab Noninferior to Aflibercept in Early Study

A small phase 2 study suggests that brolucizumab is as safe and effective as aflibercept for treating patients with age-related macular degeneration.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news